abstract |
An immunogenic composition for use in reducing one or more of the following symptoms associated with PCV2 infection: runny nose, increased mortality rate, wherein the composition comprises protein expressed by PCV2 ORF2 and is capable of causing or potentiating an immune response against PCV2, and where the reduction of symptoms is obtained by a single administration of the composition to pigs not older than 6 weeks of life. |